Sarah Lewington

• Body-mass index and all-cause mortality - Authors' reply.

  Di Angelantonio E. et al, (2017), Lancet, 389, 2285 - 2286

• The Role of Emerging Risk Factors in Cardiovascular Outcomes.

  Lacey B. et al, (2017), Curr Atheroscler Rep, 19

• Systolic Blood Pressure and Vascular Disease in Men Aged 65 Years and Over: The HIMS (Health in Men Study).

  Lacey B. et al, (2017), Hypertension, 69, 1053 - 1059

• Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study.

  Yang L. et al, (2017), Int J Epidemiol, 46, 502 - 512

• Adiposity and Blood Pressure in 110 000 Mexican Adults.

  Gnatiuc L. et al, (2017), Hypertension, 69, 608 - 614

• Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.

  Herrington W. et al, (2017), Hypertension, 69, 314 - 322

• Diabetes and Cause-Specific Mortality in Mexico City.

  Alegre-Díaz J. et al, (2016), N Engl J Med, 375, 1961 - 1971

• Association of Random Plasma Glucose Levels With the Risk for Cardiovascular Disease Among Chinese Adults Without Known Diabetes.

  Bragg F. et al, (2016), JAMA Cardiol, 1, 813 - 823

• Uncontrolled Hypertension and Risk of Cardiovascular Mortality in China-Reply.

  Lewington S. et al, (2016), JAMA Intern Med, 176

• OC04_04 Extreme Cardiac and Renal Mortality From Diabetes: 12-Year Blood-Based Prospective Study of 150,000 Mexican Adults

  Alegre-Díaz J. et al, (2016), Global Heart, 11, s5 - s5

• The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China.

  Lewington S. et al, (2016), JAMA Intern Med, 176, 524 - 532

• Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.

  Herrington W. et al, (2016), Circ Res, 118, 535 - 546

• Physical activity and vascular disease in a prospective cohort study of older men: The Health In Men Study (HIMS).

  Lacey B. et al, (2015), BMC Geriatr, 15

• Diabetes and cause-specific mortality: evidence from 55 000 deaths in 700 000 adults in 44 studies from the Prospective Studies Collaboration

  Gnatiuc L. et al, (2015), Diabetologia (2015) 58: 1., 58, S4 - S4

• Diabetes and cause-specific mortality: evidence from 55 000 deaths in 700 000 adults in 44 prospective studies

  Gnatiuc L. et al, (2015), Eur Heart J (2015) 36 (suppl 1): 1229-1310, 36, 724 - 724

• Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China.

  Yang L. et al, (2015), Eur Heart J, 36, 1178 - 1185

• The associations of month of birth with body mass index, waist circumference, and leg length: findings from the China Kadoorie Biobank of 0.5 million adults.

  Lv J. et al, (2015), J Epidemiol, 25, 221 - 230

• The burden of hypertension in china in the 21st century: findings from the china kadoorie biobank study of 0.5 million chinese adults

  Lewington S. et al, (2014), EUROPEAN HEART JOURNAL, 35, 914 - 914

• Outdoor temperature, blood pressure and cardiovascular disease mortality among people with diagnosed cardiovascular diseases: findings from the China Kadoorie Biobank

  Yang L. et al, (2014), EUROPEAN HEART JOURNAL, 35, 556 - 556

• Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women.

  Lewington S. et al, (2014), Int J Epidemiol, 43, 1252 - 1262

• Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.

  Clarke R. et al, (2014), Am J Clin Nutr, 100, 657 - 666

• Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

  Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration None., (2014), Lancet Diabetes Endocrinol, 2, 634 - 647

• Alcohol and mortality in Russia: prospective observational study of 151,000 adults.

  Zaridze D. et al, (2014), Lancet, 383, 1465 - 1473

• Erratum: Alcohol and mortality in Russia: Prospective observational study of 151 000 adults (Lancet (2014) 383 (1465-1473))

  Zaridze D. et al, (2014), The Lancet, 383

• Alcohol consumption and mortality: the Khon Kaen Cohort Study, Thailand.

  Kamsa-ard S. et al, (2014), J Epidemiol, 24, 154 - 160

• Alcohol and mortality in Russia: Prospective observational study of 151 000 adults

  Zaridze D. et al, (2014), The Lancet, 383, 1465 - 1473

• A review on metaanalysis of biomarkers: Promises and pitfalls

  Lewington S. et al, (2014), Biochimica Clinica, 38, 330 - 343

• The prevalence of abdominal aortic aneurysm, carotid stenosis, peripheral arterial disease and atrial fibrillation among 280,000 screened British and Irish Adults

  Bulbulia R. et al, (2013), VASCULAR MEDICINE, 18, 155 - 155

• Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates.

  Millwood IY. et al, (2013), Int J Epidemiol, 42, 816 - 827

• [Seasonal variation of blood pressure and related factors in Chinese adults: a survey of over 50 000 people in Suzhou, China].

  Zhang ZJ. et al, (2013), Zhonghua Liu Xing Bing Xue Za Zhi, 34, 316 - 320

• Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.

  Vollset SE. et al, (2013), Lancet, 381, 1029 - 1036

• Association between smoking and mortality: Khon Kaen cohort study, Thailand.

  Kamsa-Ard S. et al, (2013), Asian Pac J Cancer Prev, 14, 2643 - 2647

• A review on metaanalysis of biomarkers: promises and pitfalls.

  Lewington S. et al, (2012), Clin Chem, 58, 1192 - 1204

• Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank.

  Lewington S. et al, (2012), J Hypertens, 30, 1383 - 1391

• SEASONAL VARIATION IN BLOOD PRESSURE AMONG CHINESE ADULTS: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA

  Lewington S. et al, (2011), JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 65, A14 - A14

• PREVALENCE AND PATTERNS OF ALCOHOL CONSUMPTION IN CHINESE MEN AND WOMEN: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA

  Millwood I. et al, (2011), JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 65, A273 - A273

• ADIPOSITY AND ITS CONTRIBUTION TO INDIVIDUAL AND REGIONAL DIFFERENCES IN BLOOD PRESSURE: THE KADOORIE BIOBANK STUDY OF 0.5 MILLION PEOPLE IN CHINA

  Hong LS. et al, (2011), JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 65, A252 - A252

• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  Rao Kondapally Seshasai S. et al, (2011), N Engl J Med, 364, 829 - 841

• Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.

  Clarke R. et al, (2011), J Inherit Metab Dis, 34, 83 - 91

• Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials

  Clarke R. et al, (2011), Journal of Inherited Metabolic Disease, 34, 83 - 91

• Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

  Clarke R. et al, (2010), Arch Intern Med, 170, 1622 - 1631

• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

  Emerging Risk Factors Collaboration None. et al, (2010), Lancet, 375, 2215 - 2222

• Major lipids, apolipoproteins, and risk of vascular disease.

  Emerging Risk Factors Collaboration None. et al, (2009), JAMA, 302, 1993 - 2000

• The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.

  Parish S. et al, (2009), Eur Heart J, 30, 2137 - 2146

• Body-mass index and mortality - Authors' reply

  Whitlock G. et al, (2009), The Lancet, 374

• Body-mass index and mortality Reply

  Whitlock G. et al, (2009), LANCET, 374, 114 - 114

• Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

  Fibrinogen Studies Collaboration None. et al, (2009), Stat Med, 28, 1218 - 1237

• Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies.

  Fibrinogen Studies Collaboration None., (2009), Stat Med, 28, 1067 - 1092

• Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.

  Prospective Studies Collaboration None. et al, (2009), Lancet, 373, 1083 - 1096

• Measures to assess the prognostic ability of the stratified Cox proportional hazards model.

  Fibrinogen Studies Collaboration None., (2009), Stat Med, 28, 389 - 411

• Cholesterol, statins, and mortality - Reply

  Lewington S. et al, (2008), LANCET, 371, 1162 - 1163

• Cholesterol, statins, and mortality - Authors' reply

  Lewington S. et al, (2008), The Lancet, 371, 1162 - 1163

• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths (vol 370, pg 1829, 2007)

  Lewington S. et al, (2008), LANCET, 372, 292 - 292

• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  Prospective Studies Collaboration None. et al, (2007), Lancet, 370, 1829 - 1839

• Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

  Fibrinogen Studies Collaboration None. et al, (2007), Am J Epidemiol, 166, 867 - 879

• The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

  Emerging Risk Factors Collaboration None. et al, (2007), Eur J Epidemiol, 22, 839 - 869

• Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.

  Clarke R. et al, (2007), Clin Chem Lab Med, 45, 1575 - 1581

• Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.

  Clarke R. et al, (2007), Curr Opin Clin Nutr Metab Care, 10, 32 - 39

• Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.

  Fibrinogen Studies Collaboration None. et al, (2006), Int J Epidemiol, 35, 1570 - 1578

• Lymphotoxin-α gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study

  Clarke R. et al, (2006), PLoS Genetics, 2, 0990 - 0996

• Trans fatty acids and coronary heart disease - Food labels should list these as well as cholesterol and saturated fat

  Clarke R. and Lewington S., (2006), BRITISH MEDICAL JOURNAL, 333, 214 - 214

• Trans fatty acids and coronary heart disease.

  Clarke R. and Lewington S., (2006), BMJ, 333

• Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study.

  Clarke R. et al, (2006), PLoS Genet, 2

• Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

  B-Vitamin Treatment Trialists' Collaboration None., (2006), Am Heart J, 151, 282 - 287

• The association between homocysteine and myocardial infarction is independent of age, sex, blood pressure, cholesterol, smoking and markers of inflammation: the Glasgow Myocardial Infarction Study.

  Woodward M. et al, (2006), Blood Coagul Fibrinolysis, 17, 1 - 5

• Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.

  Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374

• Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk

  Lewington S. and Clarke R., (2005), Circulation, 112, 3373 - 3374

• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis

  Danesh J. et al, (2005), Journal of the American Medical Association, 294, 1799 - 1809

• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  Fibrinogen Studies Collaboration None. et al, (2005), JAMA, 294, 1799 - 1809

• Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials

  Clarke R. et al, (2005), AMERICAN JOURNAL OF CLINICAL NUTRITION, 82, 806 - 812

• Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.

  Den Heijer M. et al, (2005), J Thromb Haemost, 3, 292 - 299

• Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.

  Lowe GD. et al, (2004), Eur Heart J, 25, 252 - 259

• Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease.

  Fibrinogen Studies Collaboration None., (2004), Eur J Cardiovasc Prev Rehabil, 11, 9 - 17

• The importance of cholesterol, blood pressure and smoking for coronary heart disease.

  Lewington S., (2003), Eur Heart J, 24, 1703 - 1704

• Homocysteine and prediction of coronary heart disease and stroke

  Clarke R. and Lewington S., (2003), Klinicka Biochemie a Metabolismus, 11, 132 - 135

• Review: Usual blood pressure is directly related to vascular mortality throughout middle and old age

  Lewington S. et al, (2003), Evidence-Based Medicine, 8

• Homocysteine, renal function, and risk of cardiovascular disease.

  Clarke R. et al, (2003), Kidney Int Suppl, S131 - S133

• Age-specific relevance of usual blood pressure to vascular mortality.

  Adab P. et al, (2003), Lancet, 361

• Age-specific relevance of usual blood pressure to vascular mortality.

  Franklin SS. et al, (2003), Lancet, 361

• Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies.

  Lewington S. et al, (2003), J Cardiovasc Risk, 10, 143 - 148

• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  Lewington S., (2003), LANCET, 361, 1060 - 1060

• Homocysteine and risk of cardiovascular disease and venous thrombosis

  Clarke R. et al, (2003), THROMBOSIS: FUNDAMENTAL AND CLINICAL ASPECTS, 353 - 370

• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  Lewington S. et al, (2002), Lancet, 360, 1903 - 1913

• Surprising evidence about associations between body mass index and risks of coronary heart disease and stroke.

  Whitlock G. and Lewington S., (2002), Arch Intern Med, 162, 2490 - 2491

• Surprising evidence about associations between body mass index and risks of coronary heart disease and stroke [2] (multiple letters)

  Whitlock G. et al, (2002), Archives of Internal Medicine, 162, 2490 - 2491

• Homocysteine and coronary heart disease.

  Clarke R. and Lewington S., (2002), Semin Vasc Med, 2, 391 - 399

• Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies.

  Whitlock G. et al, (2002), Semin Vasc Med, 2, 369 - 381

• Blood pressure and coronary heart disease: a review of the evidence.

  Lawes CM. et al, (2002), Semin Vasc Med, 2, 355 - 368

• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  Homocysteine Studies Collaboration None., (2002), JAMA, 288, 2015 - 2022

• Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.

  Huxley R. et al, (2002), Semin Vasc Med, 2, 315 - 323

• Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis.

  Danesh J. et al, (2002), Eur Heart J, 23, 371 - 375

• Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.

  Clarke R. et al, (2002), Eur Heart J, 23, 286 - 293

• Corticosteroids for acute ischaemic stroke.

  Qizilbash N. et al, (2002), Cochrane Database Syst Rev

• Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.

  Clarke R. et al, (2001), J Cardiovasc Risk, 8, 363 - 369

• Tacrine for Alzheimer's disease.

  Qizilbash N. et al, (2000), Cochrane Database Syst Rev

• Corticosteroids for acute ischaemic stroke.

  Qizilbash N. et al, (2000), Cochrane Database Syst Rev

• Corticosteroids for acute ischaemic stroke.

  Qizilbash N. et al, (2000), Cochrane database of systematic reviews (Online)

• Blood pressure, cholesterol, and common causes of death: A review

  Lewington S. and MacMahon S., (1999), American Journal of Hypertension, 12

• Collaborative overview ('meta-analysis') of prospective observational studies of the associations of usual blood pressure and usual cholesterol levels with common causes of death: protocol for the second cycle of the Prospective Studies Collaboration.

  Prospective Studies Collaboration None., (1999), J Cardiovasc Risk, 6, 315 - 320

• Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.

  Lewington S. and MacMahon S., (1999), Am J Hypertens, 12, 96S - 98S

• Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.

  Clarke R. et al, (1999), Am J Epidemiol, 150, 341 - 353

• Collaborative overview ('Meta-Analysis') of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration

  Iso H. et al, (1999), European Journal of Preventive Cardiology, 6, 315 - 320

• Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.

  Danesh J. and Lewington S., (1998), J Cardiovasc Risk, 5, 229 - 232

• 3.1 Stroke, coronary heart disease, cholesterol and blood pressure

  Lewington SL. et al, (1997), Journal of Hypertension, 15

• Cholesterol and risk of stroke.

  Boysen G. and Lindenstrøm E., (1996), Lancet, 347

• Cholesterol and risk of stroke - Reply

  Qizilbash N. et al, (1996), LANCET, 347, 762 - 762

• Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

  (1995), Lancet, 346, 1647 - 1653

Recent Publications

• Body-mass index and all-cause mortality - Authors' reply.

  Di Angelantonio E. et al, (2017), Lancet, 389, 2285 - 2286

• The Role of Emerging Risk Factors in Cardiovascular Outcomes.

  Lacey B. et al, (2017), Curr Atheroscler Rep, 19

• Systolic Blood Pressure and Vascular Disease in Men Aged 65 Years and Over: The HIMS (Health in Men Study).

  Lacey B. et al, (2017), Hypertension, 69, 1053 - 1059

• Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study.

  Yang L. et al, (2017), Int J Epidemiol, 46, 502 - 512

• Adiposity and Blood Pressure in 110 000 Mexican Adults.

  Gnatiuc L. et al, (2017), Hypertension, 69, 608 - 614